Ketamine in Status Epilepticus: How Soon Is Now?

医学 癫痫持续状态 氯胺酮 重症监护医学 精神科 癫痫 医疗急救
作者
Giuseppe Magro
出处
期刊:Neurology International [PAGEPress (Italy)]
卷期号:17 (6): 83-83 被引量:8
标识
DOI:10.3390/neurolint17060083
摘要

Status epilepticus (SE) is a neurological emergency. Current evidence dictates a step-by-step approach with a first line of therapy consisting of benzodiazepines (BDZs). In many situations, the currently approved approach does not terminate a BDZ-resistant SE. This happens in Stage 1 Plus, a framework designed by the author to recognize cases of probable benzodiazepine-resistant status epilepticus even before treatment initiation. These cases include Prolonged SE (SE lasting > 10 min), the absence of prominent motor phenomena, and acute etiology (primary central nervous system etiologies most of all). BDZ-refractory SE cases (Stage 1 Plus) might require a different approach, one targeting the unresponsive GABA signaling state mediated by NMDA/AMPA receptors, such as combined polytherapy with Ketamine from the start. These considerations stem from the receptor trafficking hypotheses: in prolonged seizure activity and primary central nervous system etiologies, GABA receptors get internalized and move away from synapses, and therefore, SE becomes resistant to BDZ. A rational polytherapy that might restore the unresponsiveness to BDZ in SE should include NMDA antagonists, such as Ketamine. Ketamine has proven effective in many experimental models of status epilepticus, and much evidence is gathering supporting its use in humans, especially in refractory and super-refractory SE. We lack studies evaluating combined polytherapy in SE, especially in the early phases. The author suggests here that Ketamine should be used along with first-line BDZ in the early SE stage falling in the category of Stage 1 Plus and as a first-line anesthetic infusion drug in refractory SE, especially in cases progressing from Stage 1 Plus, eventually adding continuous midazolam/propofol infusion in later phases. This systematic review's objective is to summarize the presently available evidence of the early use of combined polytherapy that includes Ketamine, along with the currently available evidence of Ketamine use in early, established, and refractory SE. Nine studies were included. Boluses of Ketamine and Midazolam are effective in pediatric convulsive Stage 1 Plus SE. The results show that earlier Ketamine administration (especially within 12 h of SE onset) was significantly associated with improved seizure control, with a more favorable safety profile than Midazolam in refractory SE. Notably, a dosage of less than 0.9 mg/kg/h proves ineffective in terminating SE. Ketamine has the advantage of preventing intubation, possibly shortening the length of stay in the intensive care unit.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
奶油焖虾发布了新的文献求助10
1秒前
梓木完成签到 ,获得积分10
1秒前
毕月乌完成签到,获得积分10
1秒前
饭团发布了新的文献求助10
1秒前
2秒前
EKKO完成签到,获得积分10
2秒前
Cherish完成签到,获得积分10
3秒前
木春完成签到,获得积分10
3秒前
4秒前
QXX发布了新的文献求助10
4秒前
ding的应助被ReEscort采纳,获得10
5秒前
深情安青的应助被lulurie采纳,获得10
5秒前
5秒前
开开开完成签到,获得积分10
5秒前
6秒前
6秒前
1103发布了新的文献求助30
7秒前
8秒前
Lily发布了新的文献求助10
8秒前
9秒前
iNk的应助被Hao123采纳,获得10
9秒前
打打的应助被NoMigraine采纳,获得10
9秒前
ding的应助被拼搏的乐双采纳,获得10
10秒前
10秒前
10秒前
10秒前
快乐的冰棍完成签到,获得积分20
10秒前
115发布了新的文献求助10
10秒前
奶油焖虾完成签到,获得积分10
10秒前
10秒前
11秒前
12秒前
12秒前
领导范儿的应助被fisher采纳,获得30
12秒前
dny完成签到,获得积分10
12秒前
未知探索者完成签到 ,获得积分10
13秒前
科研通AI6.2的应助被Ksharp10采纳,获得30
13秒前
大气十三完成签到,获得积分10
13秒前
英俊的铭的应助被深情的碧蓉采纳,获得10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156